11 February, 2025 Strengthening Pharma IP: China’s Boost to Data and Market Exclusivity By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...
19 May, 2022 New Draft Implementing Regulations propose key changes for pharmaceuticals in China By Alison Wong Martoe Xu On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations of the Drug...